SINOPHARM GRP CO. H YC 1/ CNE100000FN7 /
| 5/13/2024 10:59:55 PM | Chg. +0.073 | Volume | Bid10:59:55 PM | Ask10:59:55 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 2.596EUR | +2.89% | - Turnover: - |
2.596Bid Size: - | 2.657Ask Size: - | 3.62 bill.EUR | - | - |
Fundamentals
| FY 2023 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | 2.90 CNY | 6.23% |
| EPS Diluted: | - CNY | 6.23% |
| Revenues per Share: | 444.60 CNY | 8.05% |
| Book Value per Share: | 55.58 CNY | 9.57% |
| Cash Flow per Share: | 12.80 CNY | -18.08% |
| Dividend per Share: | 0.87 CNY | 6.10% |
| Total | in mill. | |
| Revenues: | 596,569.57 CNY | 8.05% |
| Net Income: | 9,053.76 CNY | 6.19% |
| Operating Cash Flow: | 17,173.03 CNY | - |
| Cash and Cash Equivalents: | 63,808.54 CNY | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | 7.11 | 6.39 |
| P/S Ratio: | 0.05 | 0.04 |
| P/BV ratio: | 0.37 | 0.33 |
| P/CF Ratio: | 1.61 | 1.45 |
| PEG: | 1.14 | 1.03 |
| Earnings Yield: | 14.07% | 15.66% |
| Dividend Yield: | 4.22% | 4.70% |
| Market Capitalization | ||
| Market Capitalization: | 3.62 bill. EUR | 3.18 bill. EUR |
| Free Float Market Cap.: | - EUR | - EUR |
| Market Cap. / Employee: | - EUR | - EUR |
| Shares Outstanding: | 1.34 bill. | |
Profitability
| Gross Profit Margin: | 8.13% |
| EBIT Margin: | 3.39% |
| Net Profit Margin: | 1.52% |
| Return on Equity: | 12.14% |
| Return on Assets: | 2.36% |
Financial Strength
| Liquidity I / Cash Ratio: | 26.42% |
| Liquidity II / Quick Ratio: | 102.80% |
| Liquidity III / Current Ratio: | 139.48% |
| Debt / Equity Ratio: | 414.06% |
| Dynam. Debt / Equity Ratio: | 1,798.24% |
Efficiency
| Employees: | - |
| Personal Expenses / Employee: | - CNY |
| Revenues / Employee: | - CNY |
| Net Income / Employee: | - CNY |
| Total Assets / Employee: | - CNY |
| * Fiscal Year End: | 12/31/2023 |
| Accounting Standard: | HKFRS |
| Currency: | CNY |
